ORKA

Oruka Therapeutics
ORKA

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $1.15M invested in Oruka Therapeutics in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$12K
2
+$6K
3
+$5.6K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.78K
5
TRCT
Tower Research Capital (TRC)
New York
+$2K

Top Sellers

1
-$58.2K
2
-$29K
3
-$15K
4
U
UBS
Switzerland
-$5K
5
Citigroup
Citigroup
New York
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$505K
2
$265K
3
$150K
4
$72K
5
$32K
6
$29K
7
$20K
8
$20K
9
$19K
10
$15K
11
$12K
12
$6K
13
$4K
14
$2K
15
–
16
–
17
–